Veeda Clinical Research Limited is an independent global full-service contract research organization (CRO) providing end-to-end support across the drug development lifecycle. Its offerings span clinical trials (early and late phase), healthy volunteer studies (bioavailability and bioequivalence), pre-clinical testing, and biopharma services including bioanalysis of large molecules. With a presence in key global markets such as North America, Europe, and Asia (including India), the company supports pharmaceutical and biotech firms in accelerating drug development and ensuring regulatory compliance.
Price Band₹0.00 |
Dates- |
GMP₹0 (-) |
Subscriptions- |
Issue Size₹185.00 Crs |
Price Band₹0.00 |
Listing AtNSE & BSE |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹185.00 Cr (0.00 Shares) |
Offer For Sale₹0.00 (1.30 Cr Shares) |
Total Issue₹185.00 Cr (1.30 Cr Shares) |
Face Value₹2 per equity share |
Investor Category | Lot | Shares | Amount | |
---|---|---|---|---|
Retail |
Minimum
1
0
0
Maximum
-
-
-
|
|||
Small HNI |
Minimum
-
-
-
Maximum
-
-
-
|
|||
Big HNI |
Minimum
-
-
-
|
The estimated Grey Market Premium of Veeda Clinical Research IPO is ₹0 per share (-)
Particulars | Allocation |
---|---|
QIB | Not less than 75% of Net Offer |
Big HNIs (NII) | Not more than 10% of Net Offer |
Small HNIs (NII) | Not more than 5% of Net Offer |
Retail | Not more than 15% of Net Offer |
Particulars | Sep-24 | Mar-24 | Mar-23 | Mar-22 |
---|---|---|---|---|
Revenue from Operations | 305.30 | 388.78 | 409.58 | 288.03 |
Profit after Tax | -24.93 | -0.36 | 42.42 | 50.46 |
Net Worth | 1,192.51 | 1,190.96 | 564.90 | 503.21 |
Total Borrowing | 405.49 | 261.69 | 48.57 | 47.20 |
Total Assets | 1,891.86 | 2,040.21 | 734.77 | 677.54 |
NAV per share (in ₹) | 189.29 | 189.04 | 106.80 | 95.14 |
EPS - Basic (in ₹) | -3.96 | -0.04 | 7.58 | 10.26 |
The financial information presented is on a consolidated basis.
KPI | Values |
---|---|
EBITDA | 18.32% |
.
.
Name | Shareholding |
---|---|
Basil Limited | 33.83% |
Name | Designation |
---|---|
Nitin Deshmukh | Chairman |
Mahesh Bhalgat | CEO & MD |
Nirmal Bhatia | CFO |
Name: Veeda Clinical Research Limited
Address: Shivalik Plaza – A, 2nd Floor, Opposite Ahmedabad Management Association, Ambawadi, Ahmedabad 380 015, Gujarat, India
Number: +91 79 6777 3000
Email: investor.relation@veedalifesciences.com
Website: www.veedalifesciences.com
Find answers to common questions that come in your mind related to IPO.
Veeda Clinical Research IPO is a Mainboard IPO having an issue size of Rs. ₹185.00 Crs. Veeda Clinical Research IPO is priced at ₹0.00 - ₹0.00 per share. The issue opens on 12 Jul 25 and closes on 12 Jul 25.
Veeda Clinical Research IPO opens on 12 Jul 25 and closes on 12 Jul 25.
The estimated Grey Market Premium of Veeda Clinical Research IPO is ₹0 per share (-).
The minimum lot size of Veeda Clinical Research IPO is 0.00 shares & the minimum application amount is Rs. 0.
The allotment date of Veeda Clinical Research IPO is 12 Jul 25.
The listing date of Veeda Clinical Research IPO is 12 Jul 25.
Veeda Clinical Research IPO is subscribed -.
Veeda Clinical Research IPO is priced at ₹0.00 - ₹0.00 per share.
Click the allotment link on Veeda Clinical Research IPO page of IPO360.